Human Epidermal Growth Factor Receptor 2 Status in Gastric Carcinomas with Distinctive Prevalent Cribriform Component

Table 3

Multivariate survival analysis by Cox regression model gastric carcinoma cases.

Variable	β	SE	Exp(β)	value
All patients ()
Stage	1.433	0.273	4.193	0.000
HER2 status	1.665	0.327	5.284	0.000
CGC patients ()
Stage	1.603	0.546	4.970	0.003
HER2 status	2.402	0.738	11.041	0.001

β: regression coefficient; SE: standard error: Exp(β): ratio of risk.